作者用重组干扰素α-2b(IFNα-2b)联合病毒唑治疗慢性丙型肝炎(CHC)20例,与单用IFNα-2b对照,随访3年余,结果满意.现报道如下.对象与方法研究对象:我院1992年～1994年收治CHC38例,分为治疗组20例和对照组18例,两组的性别、年龄、病程、临床类型及肝损程度等具可比性.8例经肝穿病理检查,临床诊断与病理诊断相符.所有患者均有明确输注血制品史,抗HCV(ELISA)和HCV-RNA(RT-PCR)均阳性. The authors used recombinant interferon α-2b (IFNα-2b) combined with ribavirin in the treatment of chronic hepatitis C (CHC) in 20 cases, compared with IFNα-2b alone, with more than 3 years follow-up, the results are reported as follows. Subjects: CHC was treated in our hospital from 1992 to 1994, 38 cases were divided into treatment group (20 cases) and control group (18 cases), the two groups were comparable in sex, age, course of disease, clinical type and degree of liver injury, Pathological examination was performed, and the clinical diagnosis was consistent with the pathological diagnosis. All patients had a clear history of blood transfusion and were positive for anti-HCV (ELISA) and HCV-RNA (RT-PCR).